Government vs science over drug and alcohol policy

  title={Government vs science over drug and alcohol policy},
  author={David J. Nutt},
  journal={The Lancet},
  • D. Nutt
  • Published 2009
  • Medicine, Psychology
  • The Lancet

Topics from this paper

The development of risk politics in the UK: Thatcher’s ‘Remarkable’ but forgotten ‘Don’t Die of Ignorance’ AIDS campaign
Thirty years on from the dramatic and unprecedented AIDS advertising campaign in the UK organised by the Conservative government of the late 1980s, this article reassesses the experience drawing uponExpand
Is there sufficient evidence that cannabis use is a risk factor for psychosis?
Abstract Accumulating evidence suggests an association between cannabis use and psychosis. However, some concerns have been raised about the nature of this association, particularly whether it mightExpand
Tailoring but not targeting: a critical analysis of “the Meth Project” aimed at Hispanic youth
This paper examines the Meth Project, a social marketing campaign that enlists violence and fear to persuade Anglo and Hispanic youth in the USA to avoid methamphetamines. Violent and graphic mediaExpand
The research publications of members of European national noncommunicable disease health advisory committees
A new indicator of research impact or influence, namely the research experience of health advisory committee members in 21 European countries, and how this relates to the burden of disease in those countries is described. Expand
It is shown that even though enhancement nowadays is occurring at an impressive rate, it cannot infer that it is a present-day phenomenon, because enhancement is a human disposition, shared between most species and has always existed. Expand
‘Crossing the line’: Criminological expertise, policy advice and the ‘quarrelling society’
In October 2009, Professor David Nutt, eminent neuropsychopharmacologist and world leading expert on drugs, was dismissed as Chair of the UK government’s Advisory Council on the Misuse of Drugs forExpand
The current situation with cannabinoids.
Incidence of psychoses among drug dependent patients in primary care with no psychiatric history: A retrospective observational matched-cohort study
There is a distinct sub-group of psychotic patients among whom drug misuse/dependence, with no prior psychiatric illness, is a risk factor for the development of psychoses, established by a retrospective observational matched-cohort design. Expand
New Zealand to establish fit for purpose regulation for new psychoactive substances.
1. Hughes B., Winstock A. R. and Reuter P. Options for regulating new psychoactive drugs: a review of recent experience. Expand


Assessing the impact of cannabis use on trends in diagnosed schizophrenia in the United Kingdom from 1996 to 2005
Examining trends in the annual prevalence and incidence of schizophrenia and psychoses, as measured by diagnosed cases from 1996 to 2005, did not find any evidence of increasing schizophrenia or psychoses in the general population. Expand
Equasy — An overlooked addiction with implications for the current debate on drug harms
  • D. Nutt
  • Medicine
  • Journal of psychopharmacology
  • 2009
In this study, this study assessed alcohol, tobacco and some other misused substances to provide anchor points that would allow non-experts and the general public to better understand the harms of drugs with which they might not have familiarity. Expand
Development of a rational scale to assess the harm of drugs of potential misuse
The methodology developed and explored the feasibility of the use of a nine-category matrix of harm, with an expert delphic procedure, to assess the harms of a range of illicit drugs in an evidence-based fashion and yielded roughly similar scores and rankings of drug harm when used by two separate groups of experts. Expand